Loss of EMP1 promotes the metastasis of human bladder cancer cells by promoting migration and conferring resistance to ferroptosis through activation of PPAR gamma signaling
Open Access
- 16 July 2022
- journal article
- research article
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 189, 42-57
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- Cortactin in cell migration and cancer at a glanceJournal of Cell Science, 2012
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityNature, 2012
- The role of peroxisome proliferator-activated receptors in carcinogenesis and chemopreventionNature Reviews Cancer, 2012
- MiR-27b targets PPARγ to inhibit growth, tumor progression and the inflammatory response in neuroblastoma cellsOncogene, 2011
- Real-Time Cancer Cell Tracking by Bioluminescence in a Preclinical Model of Human Bladder Cancer Growth and MetastasisEuropean Urology, 2011
- The Role of PPARs in CancerPPAR Research, 2008
- Continuous Nucleocytoplasmic Shuttling Underlies Transcriptional Activation of PPARγ by FABP4Biochemistry, 2007
- Urothelial tumorigenesis: a tale of divergent pathwaysNature Reviews Cancer, 2005
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001